In a study by Cen et al., where they compared the immune microenvironment in BRAF-mutated tumours to that of BRAF wild-type tumours, an increased immune cell infiltration was found along with an increased expression of immune checkpoints, e.g., PD1, PD-L1 and CTLA4 [19]. The gene discussed is PDCD1; the disease is neoplasm.